Skip to main content
Kevin Xu, MD, Psychiatry, Saint Louis, MO, Barnes-Jewish Hospital

KevinYoungXuMDMPH

Psychiatry Saint Louis, MO

Instructor in Psychiatry, Co-Director of PGY2 Addiction Psychiatry Rotation, and NIDA k12 physician scientist , Washington University School of Medicine

Dr. Xu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Xu's full profile

Already have an account?

Summary

  • I am a physician-scientist at Washington University, where I completed my psychiatry residency on the R25 research track and have joined the faculty on a NIDA k12 grant. As a pharmacoepidemiologist, I use "big data" to test how clinical trial findings generalize to the real world, especially in populations underrepresented in addictions research.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 2018 - 2022
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2018, MD/MPH
  • Columbia University
    Columbia UniversityBA, Biology, Anthropology, 2010 - 2014

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2018 - 2025
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • The Eli Robins Award For Excellence in Clinical Psychiatry, Teaching and Research Washington University School of Medicine, 2022
  • Early Career Investigator Travel Award College on Problems of Drug Dependence (CPDD), 2022
  • APA Psychiatric Research Fellowship Award American Psychiatric Association, 2022
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Life-Saving Medication for Opioid Use Disorder Underprescribed in US
    Life-Saving Medication for Opioid Use Disorder Underprescribed in USMay 19th, 2022
  • Buprenorphine Underused for OUD, Particularly Polysubstance Use
    Buprenorphine Underused for OUD, Particularly Polysubstance UseMay 13th, 2022
  • Too Few People Treated for Opioid Use Get Anti-Overdose Med
    Too Few People Treated for Opioid Use Get Anti-Overdose MedMay 13th, 2022
  • Join now to see all

Grant Support

  • Collaborative Administrative Data Research Award (Co-PI)Washington University Institute for Clinical and Translational Sciences2023–Present
  • Center for Perioperative Mental Health R03 Pilot and Feasibility Grant (PI)NIMH P50/ Wash U Center for Perioperative Mental Health2023–Present
  • Career Development Award Program in Substance Use and Substance Use Disorders (K12 scholar)NIDA2023–Present
  • American Psychiatric Association (APA) Psychiatric Research Award (PI)American Psychiatric Association and NIDA2022–Present
  • Transdisciplinary Training in Addictions Research (TranSTAR) ProgramNIDA2022–2023
  • Washington University Psychiatry Residency Research Education ProgramNIMH2018–2022

Hospital Affiliations